BNP Paribas logo

Baroda BNP Paribas Health and Wellness Fund-Reg(G)

Equity · Sectoral

13.52%

Last 1 year

Exit Load
1.00%
Expense Ratio
2.70%
Min. AmountMin. SIP Amount
₹500
Min. Lump SumMin. Lump sum
₹1,000

Historical View

This fund8.9%
vs
Nifty5010.3%

Return Calculator

Investment Type
Monthly Investment

Slide to choose

₹100₹1 L
Investment Period

Slide to choose

1 Yr5 Yr
Invested Amount
₹9,00,000
Calculated AmountCurrent Value
₹9,00,000
IRR
0.000%
Absolute Gain
+₹0 (+0.0%)

Returns & Rankings

Category: Equity Sectoral

Kotak Mahindra logoHDFC logoSBI logo63 Products
1Y3Y5YAll
Fund returns13.5%0.0%0.0%7.0%
Category average6.9%14.6%11.6%NA
Rank with in category16/55NANANA

Equity Sectoral Funds

Kotak Mahindra logoHDFC logoSBI logo63 Products
3 Yr Return
Fund Returns0.0%
Category Average14.6%
Rank with in CategoryNA

Wealthy Score

Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.

1Y Returns
13.5%
Alpha
4.34

Holding Analysis

Equity/Debt/Cash Split

  • Equity97%
  • Debt3%
  • Equity
    97%
  • Debt
    3%

Market Cap Weightage

  • Large Cap43.6%
  • Mid Cap37.5%
  • Small Cap15.9%
  • Others3%
  • Large Cap
    43.6%
  • Mid Cap
    37.5%
  • Small Cap
    15.9%
  • Others
    3%

Sector allocation

  • Healthcare93.5%
  • Debt3%
  • Financials2.6%
  • Information Technology0.9%
  • Healthcare
    93.5%
  • Debt
    3%
  • Financials
    2.6%
  • Information Technology
    0.9%

Top 10 HoldingsTop Holdings

StocksSectorPercentage
Sun Pharma.Inds.Pharmaceuticals8.58%
Divi's Lab.Pharmaceuticals8.41%
Torrent Pharma.Pharmaceuticals7.74%
Laurus LabsPharmaceuticals7.56%
Ipca Labs.Pharmaceuticals6.06%
LupinPharmaceuticals5.86%
Apollo HospitalsHealthcare5.58%
Fortis Health.Healthcare4.06%
Glenmark Pharma.Pharmaceuticals3.13%
C C IDebt Others2.95%
StocksPercentage
  • Sun Pharma.Inds.

    Pharmaceuticals

    8.58%
  • Divi's Lab.

    Pharmaceuticals

    8.41%
  • Torrent Pharma.

    Pharmaceuticals

    7.74%
  • Laurus Labs

    Pharmaceuticals

    7.56%
  • Ipca Labs.

    Pharmaceuticals

    6.06%

Peer Comparison

Baroda BNP Paribas Health and Wellness Fund-Reg(G)

1 Y Return
13.52%
3 Y Return
—
5 Y Return
—

Nifty 50

1 Y Return
-2.32%
3 Y Return
9.41%
5 Y Return
8.00%

Investment Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Fund Management

  • Ankeet Pandya

    Mr. Ankeet Pandya has overall experience of 11 years in financial markets. In the past, he was associated with InCred Asset Manangement Private Limited where he was designated as Assistant Vice President.

Riskometer

Risk Score
6
Risk Level
Very High

Advanced Ratios

AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
4.34
BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
0.50
SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
-0.11
SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
12.91
TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
0.04
P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
62.73

Tax Implication

STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year

Invest in Mutual Funds?

Start a SIP or lump sum in minutes, with zero paperwork.

wealthy

Download the Wealthy Appto enjoy efficient Trading and Investing!

Download App QR Code
google-playapp-store

Welcome to Wealthy

user
mobile
OR
google-playapp-store
Curated Investing
Curated Investing
Completely Digitalised
Completely Digitalised
Bank Grade Security
Bank Grade Security
Help Centers
Help Centers

FAQs